Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study

Background: Increased prevalence of antibiotic resistance to Helicobacter pylori (H. pylori) infection worldwide has driven the search for a new therapeutic candidate. Recently, sitafloxacin, a novel 4-quinolone agent, has emerged as a new therapeutic option for H. pylori eradication, in Japan. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Youn I, Lee, Sung Min, Chung, Jun-Won, Kim, Kyoung Oh, Kwon, Kwang An, Kim, Yoon Jae, Kim, Jung Ho, Lee, Sun Mi, Jeong, Jin-Yong, Park, Dong Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532961/
https://www.ncbi.nlm.nih.gov/pubmed/34680822
http://dx.doi.org/10.3390/antibiotics10101242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532961/
https://www.ncbi.nlm.nih.gov/pubmed/34680822
http://dx.doi.org/10.3390/antibiotics10101242

Ejemplares similares